Clinical Trials Logo

Clinical Trial Summary

This study shows how careful ophthalmic examination of two patients showed signs of simultaneous bilateral retinal emboli. Starting from this point significant, life threatening, underlying reasons were found and treated.


Clinical Trial Description

Two patients were found to have signs of simultaneous bilateral retinal emboli. One patient was asymptomatic and routine ophthalmic examination showed bilateral retinal hemorrhages and exudates close to both optic discs. This patient was on anti-coagulant treatment for atrial fibrillation. The finding of bilateral signs of retinal emboli necessitated immediate blood tests and dose adjustments of her medication.

The second case did not have general symptoms other than mild evening chills and her eye examination again was the start point of intensive investigation to find the reason of her bilateral retinal emboli. Ultrasound studies revealed a life threatening reason that was urgently treated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03078387
Study type Observational
Source Dr. S.S. Michel Clinic
Contact
Status Completed
Phase
Start date August 31, 2006
Completion date December 31, 2018

See also
  Status Clinical Trial Phase
Completed NCT00154388 - Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Phase 2